[Experiences with a new topical drug Rifoderm, a rifomycin-prednisolone ointment].
D000287:Administration, Topical; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009824:Ointments; D011239:Prednisolone; D012293:Rifampin / Q000627:therapeutic use*; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D012882:Skin Tests; D013203:Staphylococcal Infections / Q000188:drug therapy
D000891:Anti-Infective Agents, Local; D000893:Anti-Inflammatory Agents; D009824:Ointments; D011239:Prednisolone; D012293:Rifampin
Erfahrungen mit dem neuen Lokaltherapeutikum Rifoderm, einer Rifamycin-Prednisolonsalbe.